Search Results 191-200 of 15920 for pharmacogenetics
The Copland Cancer Biology and Translational Research Lab at Mayo Clinic is studying novel genetic targets for specific subtypes of cancer.
Dr. Springer's Translational Cell Biology of Parkinson's Disease Lab at Mayo Clinic studies PINK1/PRKN (Parkin)-directed mitochondrial quality control.
Gene expression can amplify the risk of neurodegenerative diseases for patients, but researchers are still figuring out which genes have an outsized effect ...
About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...
This study is being done to create a "resource" of samples that can be used to improve our ability to diagnose and treat MN, IgAN, MPGN, FSGS/MCD, Lupus ...
A PSP genome-wide association study (GWAS) identified six novel risk loci, in addition to the established H1 haplotype on chromosome 17 at the tau gene (MAPT) ...
1 in subjects with inoperable or advanced intrahepatic cholangiocarcinoma (iCCA) whose tumors harbor FGFR2 gene fusions (by FISH performed by the central ...
Mayo Clinic's Department of Clinical Genomics offers adults and children comprehensive evaluation and care for inherited disorders.
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...
The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.